Literature DB >> 2466720

Prediction of neurodevelopmental impairment at four years from brain ultrasound appearance of very preterm infants.

A M Costello1, P A Hamilton, J Baudin, J Townsend, B C Bradford, A L Stewart, E O Reynolds.   

Abstract

The neurodevelopmental status of 171 very preterm infants whose brains had been scanned prospectively with ultrasound was assessed blind at four years using a wide range of tests, including tests of cognitive function. Highly significant correlations were found between the ultrasound appearance of the brain and outcome. The probability of a major neurodevelopmental impairment among the 137 children who had a normal ultrasound scan or uncomplicated periventricular haemorrhage at discharge from the unit was 7 per cent; and for any neurodevelopmental impairment (major plus minor) it was 22 per cent. The probabilities for major, or any, neurodevelopmental impairment among the 18 children who had ventricular dilatation were 33 and 50 per cent, respectively; and for the 16 with hydrocephalus and/or cerebral atrophy (loss of brain-tissue from any cause) the probabilities were 56 and 69 per cent. Impairments predicted from lesions detected by ultrasound were largely neurological. There was no evidence that cognitive impairments could be predicted among infants free of neurological impairments.

Entities:  

Mesh:

Year:  1988        PMID: 2466720     DOI: 10.1111/j.1469-8749.1988.tb14633.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  14 in total

1.  Neonatal cranial ultrasound interpretation: a clinical audit.

Authors:  P R Reynolds; R C Dale; F M Cowan
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-03       Impact factor: 5.747

2.  The neurodevelopmental progress of infants less than 33 weeks into adolescence.

Authors:  F O'Brien; S Roth; A Stewart; L Rifkin; T Rushe; J Wyatt
Journal:  Arch Dis Child       Date:  2004-03       Impact factor: 3.791

3.  Developmental outcome of the use of etamsylate for prevention of periventricular haemorrhage in a randomised controlled trial.

Authors:  J Schulte; J Osborne; J W T Benson; R Cooke; M Drayton; J Murphy; J Rennie; B Speidel
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-01       Impact factor: 5.747

4.  Randomised trial of early tapping in neonatal posthaemorrhagic ventricular dilatation. Ventriculomegaly Trial Group.

Authors: 
Journal:  Arch Dis Child       Date:  1990-01       Impact factor: 3.791

5.  Use of the CRIB (clinical risk index for babies) score in prediction of neonatal mortality and morbidity.

Authors:  R H de Courcy-Wheeler; C D Wolfe; A Fitzgerald; M Spencer; J D Goodman; H R Gamsu
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-07       Impact factor: 5.747

Review 6.  Magnetic resonance imaging in perinatal asphyxia.

Authors:  E Martin; A J Barkovich
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-01       Impact factor: 5.747

7.  Significance of ultrasound appearances in the neurological development and cognitive abilities of preterm infants at 5 years.

Authors:  C L Fawer; A Calame
Journal:  Eur J Pediatr       Date:  1991-05       Impact factor: 3.183

Review 8.  Neurodevelopmental outcomes after ventriculoperitoneal shunt placement in children with non-infectious hydrocephalus: a meta-analysis.

Authors:  Mirna Sobana; Danny Halim; Jenifer Kiem Aviani; Uni Gamayani; Tri Hanggono Achmad
Journal:  Childs Nerv Syst       Date:  2021-01-21       Impact factor: 1.475

9.  Randomised trial of early tapping in neonatal posthaemorrhagic ventricular dilatation: results at 30 months. Ventriculomegaly Trial Group.

Authors: 
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-03       Impact factor: 5.747

10.  Neonatal brain injury and neuroanatomy of memory processing following very preterm birth in adulthood: an fMRI study.

Authors:  Anastasia K Kalpakidou; Matthew P Allin; Muriel Walshe; Vincent Giampietro; Kie-woo Nam; Philip McGuire; Larry Rifkin; Robin M Murray; Chiara Nosarti
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.